Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC) Meeting Abstract


Authors: Iyengar, N. M.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N. U.; Moy, B.; Come, S. E.; Winer, E. P.; Norton, L.; Hudis, C.; Dang, C. T.
Abstract Title: Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Meeting Title: 2013 Breast Cancer Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 26 Suppl.
Meeting Dates: 2013 Sep 7-9
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-09-10
Start Page: 167
Language: English
ACCESSION: WOS:000335564700137
PROVIDER: wos
DOI: 10.1200/jco.2013.31.26_suppl.167
Notes: Meeting Abstract: 167 -- Breast Cancer Symposium -- SEP 07-09, 2013 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Patrick Glyn Morris
    116 Morris
  3. Clifford Hudis
    905 Hudis
  4. Larry Norton
    758 Norton
  5. Chau Dang
    271 Dang
  6. Richard M Steingart
    174 Steingart
  7. Kevin Oeffinger
    296 Oeffinger
  8. Carol Chen
    40 Chen
  9. Neil Mukund Iyengar
    150 Iyengar
  10. Alyson Merced
    13 Merced
  11. Robert James Lehman
    10 Lehman